Evidence map›Paper›PMID 24134061›Full record

ArticleBMC neuroscience2013

Early consolidation of development and physiology of an identified presynaptic nerve terminal.

Matthew Laviolette, Bryan A Stewart

Abstract read
In one paragraph

Article in BMC neuroscience, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Matthew Laviolette
Bryan A StewartDepartment of Biology, University of Toronto Mississauga, 3359 Mississauga Rd, Mississauga, ON L5L 1C6, Canada. bryan.stewart@utoronto.ca.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundA central objective in the field of neurobiology is to understand the developmental plasticity of neurons. The pursuit of this objective has revealed the presence of critical periods in neural development. Here, critical periods are defined as developmental time windows during which neural remodeling can take place; outside of these times neural plasticity is reduced. We have taken advantage of transgenic technology at the Drosophila melanogaster neuromuscular junction (NMJ) to investigate developmental plasticity and critical period determination of an identifiable nerve terminal.

resultsUsing temperature-dependent Gal80 control of transgene expression, we regulated the expression of dNSF2E/Q, a dominant-negative version of the Drosophila NSF2 gene, by shifting developing embryos and larvae between permissive and restrictive temperatures. dNSF2E/Q reduces synaptic strength and causes tremendous overgrowth of the neuromuscular junctions. We therefore measured synaptic transmission and synaptic morphology in two temperature-shift paradigms. Our data show that both physiological and morphological development is susceptible to dNSF2E/Q perturbation within the first two days.

conclusionOur data support the view that individual motor neurons in Drosophila larvae possess a critical window for synapse development in the first one to two days of life and that the time period for morphological and physiological plasticity are not identical. These studies open the door to further molecular genetic analysis of critical periods of synaptic development.

Indexed as

AnimalsAnimals, Genetically ModifiedCritical Period, PsychologicalDrosophila melanogasterNeuromuscular JunctionNeuronal PlasticityPresynaptic Terminals

Identifiers

PMID24134061
PMCPMC4015271

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.